Tens of millions of JnJ COVID shots sit at Baltimore factory: Report Ruchika Sharma29 Oct 2021 10:00 AM ISTNew Delhi: An estimated 30 million to 50 million doses of Johnson & Johnson's COVID-19 vaccine made early this year sits idle in Emergent...
Johnson and Johnson puts newly created subsidiary into bankruptcy over baby powder claims Roshni Dhar19 Oct 2021 4:00 PM ISTJohnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused...
Health Bulletin 16/October/ 2021 Roshni Dhar16 Oct 2021 6:00 PM ISTHere are the top Health stories of the dayNMC directs major changes in Medical Education Curriculum, Textbooks to make them LGBTQIA friendlyComplying...
JnJ puts newly created subsidiary into bankruptcy over baby powder claims MD Editorial Team15 Oct 2021 5:05 PM ISTNew Delhi: Johnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based...
JnJ, Moderna COVID vaccine third dose efficacy to be evaluated by USFDA this week MD Bureau13 Oct 2021 2:00 PM ISTWashington: The US Food and Drug Administration is expected to evaluate the efficacy of Moderna and Johnson & Johnson's third dose of Covid...
Use only ICMR approved kits for rapid serological test: CDSCO panel tells JnJ on Ad26.COV2.S study Medical Dialogues Team10 Oct 2021 11:30 AM ISTNew Delhi: Reiterating the prior suggestion, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has opined...
Merck's plant gets European nod to make JnJ Covid-19 vaccine Medical Dialogues Bureau8 Oct 2021 4:21 PM ISTNew Delhi: The European Medicines Agency (EMA) said on Thursday it had approved U.S. drugmaker Merck & Co Inc's manufacturing site in West Point,...
JnJ plans to seek USFDA authorization for booster shot of Covid-19 vaccine Ruchika Sharma5 Oct 2021 2:30 PM ISTNew Delhi: Johnson & Johnson is planning to ask U.S. federal regulators this week to authorize a booster shot of its COVID-19 vaccine, the...
Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sept 2021 10:30 AM ISTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune...
JnJ HIV vaccine fails Imbokodo trial Ruchika Sharma1 Sept 2021 4:54 PM ISTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Pfizer COVID vaccine for 5-12 years likely to get nod by October: Ex-USFDA Chief MD Bureau30 Aug 2021 12:32 PM ISTWashington: US drug maker Pfizer's Covid-19 vaccine is likely to get authorisation for providing vaccines to children aged between 5 to 12 by October,...
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 9:00 AM ISTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people...
